Cornercap Investment Counsel Inc Nkarta, Inc. Transaction History

Cornercap Investment Counsel Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$1.39 - $2.29 $765 - $1,261	-551 Reduced 1.41%	38,645 $53,000
Q1 2023 May 11, 2023	BUY	$3.37 - $6.3 $58,001 - $108,429	17,211 Added 78.29%	39,196 $139,000
Q4 2022 Feb 13, 2023	BUY	$5.14 - $14.35 $113,002 - $315,484	21,985 New	21,985 $131,000

129

66.5M

173K

20K

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $145M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

Stay updated on Cornercap Investment Counsel Inc with notifications on news.